Azithromycin 250 mg + Lactic Acid Bacillus 60 MS Tablet

Azithromycin 250 mg + Lactic Acid Bacillus 60 MS Tablet is a tablet formulated with Azithromycin 250 mg + Lactic Acid Bacillus 60 MS. The active ingredient profile is Azithromycin; Lactic Acid Bacillus, placing the product in the macrolide antibiotic + probiotic combination category. Azithromycin provides macrolide antibacterial activity, while Lactic Acid Bacillus is included as a probiotic adjunct intended to support gastrointestinal microbial balance. It is supplied as an oral solid-dosage tablet formulation; administration details should follow the approved product literature. For website cataloguing, the composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. This product is intended for professional pharmaceutical presentation and should not be described using unapproved efficacy, cure or superiority claims. Clinical selection should depend on the patient, diagnosis, susceptibility or symptom profile, and the prescriber’s judgement. Prescription status, contraindications, precautions, interactions, adverse-effect information and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.